NeuroOne Medical Tech(NMTC.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
NeuroOne Medical Tech
NMTC.US
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company is based in Eden Prairie, Minnesota.
1.376 T
NMTC.USMarket value -Rank by Market Cap -/-

Financial Score

19/01/2026 Update
B
Health Care EquipmentIndustry
Industry Ranking40/176
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-91.34%E
    • Profit Margin-29.80%E
    • Gross Margin26.10%C
  • Growth ScoreA
    • Revenue YoY250.35%A
    • Net Profit YoY70.73%A
    • Total Assets YoY100.85%A
    • Net Assets YoY760.39%A
  • Cash ScoreB
    • Cash Flow Margin-335.55%D
    • OCF YoY250.35%A
  • Operating ScoreA
    • Turnover1.5A
  • Debt ScoreB
    • Gearing Ratio34.43%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    3 S&P 500 Stocks to Sell in 2026

    The S&P 500 has risen 17% over the past year, but some stocks may struggle in 2026 due to economic pressures and sector underperformance. Analysts suggest selective trimming of positions, highlighting three stocks to sell: Tesla, facing competition and declining deliveries; GE HealthCare, with declining sales and competitive pressures; and UnitedHealth, which is experiencing rising medical costs and declining Medicaid margins. Concerns about concentration risk in the index persist as market sentiment shifts.

    benzinga_article·
    US
    UNH
    -2.34%
    US
    GEHC
    -0.92%
    US
    TSLA
    -0.24%
    benzinga_article·
    US
    UNH
    -2.34%
    US
    GEHC
    -0.92%
    US
    TSLA
    -0.24%

    Legislation by Senator Hildy Angius aims to eliminate financial barriers for breast imaging in Arizona, benefiting thousands.

    In Phoenix, breast cancer organization Susan G. Komen® applauds Senator Hildy Angius (R-Bullhead City) for proposing a bill to improve access to necessary diagnostic and supplementary breast imaging. This legislation aims to remove financial obstacles hindering patients from receiving essential breast cancer screening. The high out-of-pocket expenses linked to this crucial imaging procedure, which can vary from hundreds to thousands of dollars, frequently prevent individuals from accessing the service.

    Unusual Whales·
    Unusual Whales·

    OpenAI invests heavily in brain-machine interfaces, and Altman is set to compete with Musk again

    Merge Labs, a brain-computer interface company co-founded by Sam Altman, has completed a $252 million financing round, with OpenAI as the largest investor. Among major brain-computer interface companies, only Neuralink has a single financing round that exceeds Merge. Unlike competitors such as Neuralink, Merge aims to develop non-invasive brain-computer interface devices, with plans to first develop medical products and then launch products for general consumers

    Wallstreetcn·
    NA
    OpenAI
    0.00%
    Wallstreetcn·
    NA
    OpenAI
    0.00%

    CAGW opposes codifying Most Favored Nation price controls, calling it disaster for the economy.

    CAGW opposes the codification of Most Favored Nation price controls, warning it could lead to significant economic harm. Experts predict widespread government waste and a potential disaster across sectors like healthcare and commerce. The policy may destabilize markets and worsen existing challenges, highlighting the need for careful consideration before implementing such regulatory measures.

    Unusual Whales·
    Unusual Whales·

    Merge Labs Funding: The $252M Bet on Linking Brains to AI

    Merge Labs, co-founded by Sam Altman, has raised $252 million in funding to develop brain-computer interfaces (BCIs) that connect human brains to computers. This investment aims to enhance human capabilities in the context of advancing AI technologies. OpenAI is collaborating with Merge Labs on foundational models, viewing BCIs as essential for direct interaction with AI. The lab focuses on creating high-bandwidth, safe interfaces powered by AI to interpret neural signals and translate human intent into digital actions, aiming to keep humans central in an automated future.

    StartupHub·
    NA
    OpenAI
    0.00%
    StartupHub·
    NA
    OpenAI
    0.00%
    © 2026 Longbridge｜Disclaimer